SMARTCANCERSENS
Micro/nanosensors for early cancer warning system - diagnostic and prognostic information
| Coordinatore | INSTITUTE OF TECHNOLOGY TALLAGHT
Organization address
address: OLD BLESSINGTON ROAD contact info |
| Nazionalità Coordinatore | Ireland [IE] |
| Totale costo | 584˙800 € |
| EC contributo | 584˙800 € |
| Programma | FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
| Code Call | FP7-PEOPLE-2012-IRSES |
| Funding Scheme | MC-IRSES |
| Anno di inizio | 2013 |
| Periodo (anno-mese-giorno) | 2013-01-01 - 2016-12-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
INSTITUTE OF TECHNOLOGY TALLAGHT
Organization address
address: OLD BLESSINGTON ROAD contact info |
IE (TALLAGHT DUBLIN 24) | coordinator | 85˙800.00 |
| 2 |
UNIVERSITATEA DIN BUCURESTI
Organization address
address: MIHAIL KOGALNICEANU STREET 36-46 SECTOR V contact info |
RO (BUCURESTI) | participant | 117˙000.00 |
| 3 |
LINKOPINGS UNIVERSITET
Organization address
address: CAMPUS VALLA contact info |
SE (LINKOPING) | participant | 108˙400.00 |
| 4 |
UNIVERSITE LYON 1 CLAUDE BERNARD
Organization address
address: BOULEVARD DU 11 NOVEMBRE 1918 NUM43 contact info |
FR (VILLEURBANNE CEDEX) | participant | 98˙900.00 |
| 5 |
UNIVERSIDADE DE COIMBRA
Organization address
address: PACO DAS ESCOLAS contact info |
PT (COIMBRA) | participant | 87˙700.00 |
| 6 |
UNIVERSITAT ROVIRA I VIRGILI
Organization address
address: CARRER DE ESCORXADOR contact info |
ES (TARRAGONA) | participant | 87˙000.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'Oncologists still rely heavily on biological characterisation of tumours and a limited number of biomarkers which have demonstrated clinical utility. Routine cancer diagnostic tools may not be always sensitive enough and may only detect proteins at levels corresponding to an advanced stage of the disease. Recently, new genomic and proteomic molecular tools (molecular signatures) are being employed which include genetic and epigenetic signatures, changes in gene expression, protein profiles and post-translational modification of proteins. Such advanced diagnostic tools are not always readily adapted to clinical cancer screening due to their complexity, costs and the requirement for highly-qualified operators. Novel bioanalytical methodologies for detection of specific biomarkers/ biomolecules, based on nanostructured electronic sensors (rapid, sensitive devices capable of miniaturisation and deployment on site or in small clinics), fulfill the necessary requirements and have the potential to compliment time- and labour consuming clinical analysers used in medical laboratories currently. The primary objective of this proposal, therefore, is to gather together an international and interdisciplinary consortium of ten research teams from EU Member States, Third (including ENP) countries with EU agreements on S&T, in order to share and jointly exploit knowledge and expertise in the development of micro/nanosensors as tools in early cancer diagnosis. A key scientific target is the realisation of intelligent electronic devices which respond to biomolecules such as formaldehyde, amines, metal ions, saccharides, activities of amine oxidases, arginase and glutathione-S-transferase. This will entail design, development and characterisation of nano-scale transducers suitable for testing in clinical samples.'